ProShares UltraPro Short Nasdaq Biotechnology(ZBIO:US)
Market Cap$1.55B
Key Metrics
Price$24.84
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$425.15M
EBITDA (TTM)-$235.8M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$500.22M
Total Assets$747.68M
Net Assets$335.83M
Total Debt$266.83M
Key Metrics
Price$24.84
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$425.15M
EBITDA (TTM)-$235.8M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$500.22M
Total Assets$747.68M
Net Assets$335.83M
Total Debt$266.83M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $10M | $5M | $0 | $0 | $0 | $0 | $50M | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| $77.35M | $71.31M | $47.58M | $55.16M | $47.33M | $60.62M | $40.98M | $39.7M | $27.58M | $24.78M | $14.38M | $18.91M | $19.09M | $18.99M | |
| Research and Development | $60.44M | $55.72M | $34.4M | $43.03M | $34.92M | $49.16M | $33.53M | $33.81M | $22.65M | $20.42M | $9.35M | $14.92M | $15.35M | $15.77M |
| Selling, General, and Administrative | $16.91M | $15.59M | $13.18M | $12.14M | $12.42M | $11.47M | $7.45M | $5.9M | $4.93M | $4.36M | $5.02M | $3.99M | $3.74M | $3.22M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$77.35M | -$71.31M | -$47.58M | -$55.16M | -$37.33M | -$55.62M | -$40.98M | -$39.7M | -$27.58M | -$24.78M | $35.62M | -$18.91M | -$19.09M | -$18.99M |
| -$3.64M | -$173.85M | -$3.92M | $2.96M | $3.55M | $3.45M | $2.38M | $1.73M | -$222K | $493K | -$16K | -$10.14M | -$11K | -$5K | |
| Non-Operating Interest Income | $3.02M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Non-Operating Interest Expense | $6.63M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | -$24K | -$173.85M | -$3.92M | $2.96M | $3.55M | $3.45M | $2.38M | $1.73M | -$222K | $493K | -$16K | -$10.14M | -$11K | -$5K |
Income Before Tax | -$80.99M | -$240.34M | -$51.5M | -$52.2M | -$33.78M | -$52.18M | -$38.61M | -$37.98M | -$27.8M | -$24.29M | $35.61M | -$29.05M | -$19.1M | -$18.99M |
Income Tax | $0 | $106K | $0 | $20K | -$205K | - | - | - | - | - | - | - | - | - |
Net Income | -$80.99M | -$240.44M | -$51.5M | -$52.22M | -$33.57M | -$52.6M | -$38.61M | -$37.98M | -$27.8M | -$24.59M | $35.61M | -$29.05M | -$19.1M | -$18.99M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | $0 | - | - | - | $28.12M | - | - | - |
Net Income to Common | -$80.99M | -$240.44M | -$51.5M | -$52.22M | -$33.57M | -$52.6M | -$38.61M | -$37.98M | -$27.8M | -$24.59M | $7.49M | -$29.05M | -$19.1M | -$18.99M |
Shares Outstanding (Basic) | 55.62M | 53M | 42.16M | 41.87M | 41.8M | - | 7.7M | - | 39.79M | - | 17.42M | - | 17.42M | - |
Shares Outstanding (Diluted) | 55.62M | 53M | 42.16M | 41.87M | 41.8M | - | 7.7M | - | 39.79M | - | 17.42M | - | 17.42M | - |
EPS (Basic) | -$1.46 | -$4.54 | -$1.22 | -$1.25 | -$0.80 | - | -$5.02 | - | -$0.70 | - | $0.21 | - | -$1.10 | - |
EPS (Diluted) | -$1.46 | -$4.54 | -$1.22 | -$1.25 | -$0.80 | - | -$5.02 | - | -$0.70 | - | $0.21 | - | -$1.10 | - |
EBIT | -$74.36M | -$230.42M | -$47.58M | -$55.16M | -$37.33M | -$55.62M | -$40.98M | -$39.7M | -$27.58M | -$24.78M | $35.62M | -$18.91M | -$19.09M | -$18.99M |
EBITDA | -$74.35M | -$63.73M | -$42.57M | -$55.15M | -$37.31M | -$55.59M | -$40.95M | -$39.52M | -$27.55M | -$24.75M | $35.65M | -$18.88M | -$19.06M | -$18.96M |